ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01891357
Recruitment Status : Unknown
Verified August 2015 by West German Study Group.
Recruitment status was:  Recruiting
First Posted : July 3, 2013
Last Update Posted : August 7, 2015
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
West German Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : December 2016